jueves 14 de septiembre
Sala 1
08:10 - 10:30
Primer Simposio del Grupo Uruguayo de Linfoma (GULI)
LINFOMA DE HODGKIN
Actividad con sistema interactivo (votación) y traducción simultánea
Coordinadoras:
Dra.
Victoria Irigoin
Invitado:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Presentadora:
Dra.
Isabel Moro
Panelistas:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
